TestvfBankvfforvfIntroductoryvfClinicalvfPharmacologyvf12thvfEditionvf
Ford
Introductory Clinical Pharmacol
vf vf
ogy 12th Edition Ford Test Bank
vf vf vf vf vf
, TestvfBankvfforvfIntroductoryvfClinicalvfPharmacologyvf12thvfEditionvf
Ford
1. Avfnursingvfinstructorvfisvfpreparingvfavfteachingvfplanvfforvfavfgroupvfofvfnursingvfstudentsvfa
boutvfpharmacology.vfWhenvfdescribingvfthisvftopic,vfthevfinstructorvfwouldvffocusvfthevfdiscu
ssionvfonvfwhichvfofvfthevffollowingvfasvfanvfessentialvfaspect?
A) Drugvfname
B) Drugvfclass
C) Drugvfaction
D) Drugvfsourc
evfAns:v f CvfFeedb
ack:
Pharmacologyvfisvfthevfstudyvfofvfdrugsvfandvftheirvfactionvfonvflivingvforganisms.vfThus,vfanvf
essentialvfaspectvfofvfpharmacologyvfisvfdrugvfaction.vfAnvfunderstandingvfofvfthevfdrugvfname,
vfdrugvfclass,vfandvfdrugvfsourcevfisvfimportant,vfbutvfthevfmostvfcriticalvfaspectvfrelatedvftovfph
armacologyvfisvfhowvfthevfdrugvfactsvfinvfthevfbody.
2. Avfnursingvfstudentvfisvfpreparingvftovfadministervfavfprescribedvfdrugvftovfavfpatient.vfThevfstu
dentvfreviewsvfinformationvfaboutvfthevfdrugvfandvfitsvfactions.vfWhichvfofvfthevffollowingvfwo
uldvfbevfthevfbestvfchoicevfforvfobtainingvfthisvfinformation?vfSelectvfallvfthatvfapply.
A) Nursingvfinstructor
B) Nursevfassignedvftovfthevfpatient
C) Clinicalvfdrugvfreference
D) Prescribingvfhealthvfcarevfprovider
E) Clinicalvfpharmacis
tvfAns:v f C,vfE
Feedback:
Althoughvfthevfnursingvfstudentvfcanvfaskvfthevfnursingvfinstructor,vfthevfnursevfassignedvftovft
hevfpatient,vfandvfthevfprescribingvfhealthvfcarevfprovidervfforvfinformationvfaboutvfthevfdrug,vft
hevfbestvfchoicesvfforvfdrugvfinformationvfwouldvfincludevfanvfappropriatevfdrugvfreferencevfa
ndvfthevfclinicalvfpharmacist.
3. Whenvfdescribingvfthevfvariousvftypesvfofvfmedicationsvftovfavfgroupvfofvfnursingvfstuden
ts,vfavfnursingvfinstructorvfwouldvfidentifyvfwhichvfofvfthevffollowingvfasvfavfsourcevfforvf
derivingvfmedications?vfSelectvfallvfthatvfapply.
A) Plants
B) Syntheticvfsources
C) Mold
D) Minerals
E) AnimalsvfAn
s:v f A,vfB,vfC,vfD,vfE
Feedback:
Medicationsvfarevfderivedvffromvfnaturalvfsources,vfforvfexample,vfplants,vfmolds,vfminerals,vfa
ndvfanimals,vfasvfwellvfasvfcreatedvfsyntheticallyvfinvfavflaboratory.
Pagev f 1
, TestvfBankvfforvfIntroductoryvfClinicalvfPharmacologyvf12thvfEditionvf
Ford
4. Whichvfofvfthevffollowingvfnamesvfmayvfbevfassignedvftovfavfdrugvfduringvfthevfproce
ssvfofvfdevelopment?vfSelectvfallvfthatvfapply.
A) Chemicalvfname
B) Officialvfname
C) Pharmacologicvfname
D) Tradevfname
E) Nonproprietaryvfname
vfAns:v f A,vfB,vfD,vfE
Feedback:
Throughoutvfthevfprocessvfofvfdevelopment,vfdrugsvfmayvfhavevfseveralvfnamesvfassignedvfto
vfthemvfincludingvfavfchemicalvfname,vfavfgenericvf(nonproprietary)vfname,vfanvfofficialvfname,
vfandvfavftradevforvfbrandvfname.
5. Avfdrugvfmayvfbevfclassifiedvfbyvfwhichvfofvfthevffollowing?vfSelectvfallvfthatvfapply.
A) Thevfchemicalvftypevfofvfthevfdrug'svfactivevfingredient
B) Thevfwayvfthevfdrugvfisvfusedvftovftreatvfavfspecificvfcondition
C) Thevfgenericvfnamevfofvfthevfdrug
D) Thevftradevfnamevfofvfthevfdrug
E) Thevfnonproprietaryvfnamevfofvfthevfdru
gvfAns:v f A,vfB
Feedback:
Avfdrugvfmayvfbevfclassifiedvfbyvfthevfchemicalvftypevfofvfthevfactivevfingredientvforvfbyvfthevfwa
yvfitvfisvfusedvftovftreatvfavfparticularvfcondition.vfGeneric,vftrade,vfandvfnonproprietaryvfrefervft
ovfhowvfavfdrugvfisvfnamed.
6. Avfgroupvfofvfnursingvfstudentsvfarevfreviewingvfinformationvfaboutvfthevfprocessvfofvfdru
gvfdevelopmentvfinvfthevfUnitedvfStates.vfThevfstudentsvfdemonstratevfunderstandingvfofvf
thisvfprocessvfwhenvftheyvfidentifyvfthatvfwhichvfofvfthevffollowingvfcategoriesvfarevfassigne
dvfbyvfthevfFoodvfandvfDrugvfAdministrationvftovfnewlyvfapprovedvfdrugs?vfSelectvfallvftha
tvfapply.
A) Metabolite
B) Noncontrolledvfsubstance
C) Prescription
D) Nonprescription
E) Controlledvfsubstanc
evfAns:v f C,vfD,vfE
Feedback:
Oncevfdrugsvfarevfapprovedvfforvfuse,vfthevfFDAvfassignsvfthevfdrugvftovfonevfofvfthevffollowin
gvfcategories:vfprescription,vfnonprescription,vforvfcontrolledvfsubstance.vfMetabolitevfrefersv
ftovfthevfinactivevfformvfofvfthevfdrug.vfNoncontrolledvfsubstancevfisvfavftermvfthatvfisvfnotvfuse
d.
Pagev f 2
, TestvfBankvfforvfIntroductoryvfClinicalvfPharmacologyvf12thvfEditionvf
Ford
7. Whichvfofvfthevffollowingvfwouldvfbevfmostvfimportantvfforvfthevfnursevftovfdovftovfensurevfthe
vfsafevfusevfofvfprescriptionvfdrugsvfinvfthevfinstitutionalvfsetting? vfSelectvfallvfthatvfapply.
A) Administeringvfdrugs
B) Monitoringvfclientsvfforvfdrugvfeffects
C) Prescribingvfdrugs
D) Evaluatingvfclientsvfforvftoxicvfeffects
E) Educatingvfclients/caregiversvfaboutvfdrug
svfAns:v f A,vfB,vfD,vfE
Feedback:
Invfthevfinstitutionalvfsetting,vfthevfnurse'svfrolevftovfensurevfsafevfusevfofvfprescriptionvfdrugsvf
includesvfadministeringvfdrugs,vfmonitoringvfdrugvfeffects,vfevaluatingvfforvftoxicvfeffects,vfan
dvfeducatingvfclientsvfandvfcaregiversvfaboutvfdrugs.
8. Thevfnursevfisvfhelpingvfavfclientvfreviewvfavfprescriptionvffromvfthevfhealthvfcarevfprovider.vf
Whenvfexaminingvfthevfprescription,vfwhichvfofvfthevffollowingvfwouldvfthevfnursevfexpectvf
tovffindvfdocumented?vfSelectvfallvfthatvfapply.
A) Namevfofvfthevfdrug
B) Dosagevfofvfthevfdrug
C) Routevfofvfdrugvfadministration
D) Timesvfofvfdrugvfadministration
E) Licensedvfprescriber'svfsignatur
evfAns:v f A,vfB,vfC,vfD,vfE
Feedback:
Thevfprescriptionvfmustvfcontainvfthevfclient'svfname,vfthevfnamevfofvfthevfdrug,vfthevfdosage,vft
hevfmethodvfandvftimesvfofvfadministration,vfandvfthevfsignaturevfofvfthevflicensedvfhealthvfcar
evfprovidervfprescribingvfthevfdrug.
9. Aftervfteachingvfavfgroupvfofvfnursingvfstudentsvfaboutvfnonprescriptionvfdrugs,vfthevfnursin
gvfinstructorvfdeterminesvfthatvfthevfteachingvfwasvfsuccessfulvfwhenvfthevfstudentsvfidentifyvf
whichvfofvfthevffollowing?vfSelectvfallvfthatvfapply.
A) Theyvfrequirevfavflicensedvfhealthvfcarevfprovider'svfsignature.
B) Theyvfarevfreferredvftovfasvfover-the-countervfdrugs.
C) Theyvfcanvfbevftakenvfwithoutvfriskvftovfthevfclient.
D) Theyvfhavevfcertainvflabelingvfrequirements.
E) Theyvfshouldvfbevftakenvfonlyvfasvfdirectedvfonvfthevflab
el.vfAns:v f B,vfD,vfE
Feedback:
Nonprescriptionvfdrugsvfarevfoftenvfreferredvftovfasvfover-the-
countervf(OTC)vfdrugs.vfTheyvfdovfnotvfrequirevfavfprescriptionvf(avflicensedvfhealthvfcarevfpr
ovider'svfsignature)vfbutvfdovfnotvfcomevfwithoutvfriskvftovfthevfclient.vfThevffederalvfgovernme
ntvfhasvfimposedvflabelingvfrequirementsvfofvfOTCvfdrugsvfandvftheyvfshouldvfonlyvfbevftakenvf
asvfdirectedvfonvfthevflabelvfunlessvfundervfthevfsupervisionvfofvfavfhealthvfcarevfprovider.
Pagev f 3
Ford
Introductory Clinical Pharmacol
vf vf
ogy 12th Edition Ford Test Bank
vf vf vf vf vf
, TestvfBankvfforvfIntroductoryvfClinicalvfPharmacologyvf12thvfEditionvf
Ford
1. Avfnursingvfinstructorvfisvfpreparingvfavfteachingvfplanvfforvfavfgroupvfofvfnursingvfstudentsvfa
boutvfpharmacology.vfWhenvfdescribingvfthisvftopic,vfthevfinstructorvfwouldvffocusvfthevfdiscu
ssionvfonvfwhichvfofvfthevffollowingvfasvfanvfessentialvfaspect?
A) Drugvfname
B) Drugvfclass
C) Drugvfaction
D) Drugvfsourc
evfAns:v f CvfFeedb
ack:
Pharmacologyvfisvfthevfstudyvfofvfdrugsvfandvftheirvfactionvfonvflivingvforganisms.vfThus,vfanvf
essentialvfaspectvfofvfpharmacologyvfisvfdrugvfaction.vfAnvfunderstandingvfofvfthevfdrugvfname,
vfdrugvfclass,vfandvfdrugvfsourcevfisvfimportant,vfbutvfthevfmostvfcriticalvfaspectvfrelatedvftovfph
armacologyvfisvfhowvfthevfdrugvfactsvfinvfthevfbody.
2. Avfnursingvfstudentvfisvfpreparingvftovfadministervfavfprescribedvfdrugvftovfavfpatient.vfThevfstu
dentvfreviewsvfinformationvfaboutvfthevfdrugvfandvfitsvfactions.vfWhichvfofvfthevffollowingvfwo
uldvfbevfthevfbestvfchoicevfforvfobtainingvfthisvfinformation?vfSelectvfallvfthatvfapply.
A) Nursingvfinstructor
B) Nursevfassignedvftovfthevfpatient
C) Clinicalvfdrugvfreference
D) Prescribingvfhealthvfcarevfprovider
E) Clinicalvfpharmacis
tvfAns:v f C,vfE
Feedback:
Althoughvfthevfnursingvfstudentvfcanvfaskvfthevfnursingvfinstructor,vfthevfnursevfassignedvftovft
hevfpatient,vfandvfthevfprescribingvfhealthvfcarevfprovidervfforvfinformationvfaboutvfthevfdrug,vft
hevfbestvfchoicesvfforvfdrugvfinformationvfwouldvfincludevfanvfappropriatevfdrugvfreferencevfa
ndvfthevfclinicalvfpharmacist.
3. Whenvfdescribingvfthevfvariousvftypesvfofvfmedicationsvftovfavfgroupvfofvfnursingvfstuden
ts,vfavfnursingvfinstructorvfwouldvfidentifyvfwhichvfofvfthevffollowingvfasvfavfsourcevfforvf
derivingvfmedications?vfSelectvfallvfthatvfapply.
A) Plants
B) Syntheticvfsources
C) Mold
D) Minerals
E) AnimalsvfAn
s:v f A,vfB,vfC,vfD,vfE
Feedback:
Medicationsvfarevfderivedvffromvfnaturalvfsources,vfforvfexample,vfplants,vfmolds,vfminerals,vfa
ndvfanimals,vfasvfwellvfasvfcreatedvfsyntheticallyvfinvfavflaboratory.
Pagev f 1
, TestvfBankvfforvfIntroductoryvfClinicalvfPharmacologyvf12thvfEditionvf
Ford
4. Whichvfofvfthevffollowingvfnamesvfmayvfbevfassignedvftovfavfdrugvfduringvfthevfproce
ssvfofvfdevelopment?vfSelectvfallvfthatvfapply.
A) Chemicalvfname
B) Officialvfname
C) Pharmacologicvfname
D) Tradevfname
E) Nonproprietaryvfname
vfAns:v f A,vfB,vfD,vfE
Feedback:
Throughoutvfthevfprocessvfofvfdevelopment,vfdrugsvfmayvfhavevfseveralvfnamesvfassignedvfto
vfthemvfincludingvfavfchemicalvfname,vfavfgenericvf(nonproprietary)vfname,vfanvfofficialvfname,
vfandvfavftradevforvfbrandvfname.
5. Avfdrugvfmayvfbevfclassifiedvfbyvfwhichvfofvfthevffollowing?vfSelectvfallvfthatvfapply.
A) Thevfchemicalvftypevfofvfthevfdrug'svfactivevfingredient
B) Thevfwayvfthevfdrugvfisvfusedvftovftreatvfavfspecificvfcondition
C) Thevfgenericvfnamevfofvfthevfdrug
D) Thevftradevfnamevfofvfthevfdrug
E) Thevfnonproprietaryvfnamevfofvfthevfdru
gvfAns:v f A,vfB
Feedback:
Avfdrugvfmayvfbevfclassifiedvfbyvfthevfchemicalvftypevfofvfthevfactivevfingredientvforvfbyvfthevfwa
yvfitvfisvfusedvftovftreatvfavfparticularvfcondition.vfGeneric,vftrade,vfandvfnonproprietaryvfrefervft
ovfhowvfavfdrugvfisvfnamed.
6. Avfgroupvfofvfnursingvfstudentsvfarevfreviewingvfinformationvfaboutvfthevfprocessvfofvfdru
gvfdevelopmentvfinvfthevfUnitedvfStates.vfThevfstudentsvfdemonstratevfunderstandingvfofvf
thisvfprocessvfwhenvftheyvfidentifyvfthatvfwhichvfofvfthevffollowingvfcategoriesvfarevfassigne
dvfbyvfthevfFoodvfandvfDrugvfAdministrationvftovfnewlyvfapprovedvfdrugs?vfSelectvfallvftha
tvfapply.
A) Metabolite
B) Noncontrolledvfsubstance
C) Prescription
D) Nonprescription
E) Controlledvfsubstanc
evfAns:v f C,vfD,vfE
Feedback:
Oncevfdrugsvfarevfapprovedvfforvfuse,vfthevfFDAvfassignsvfthevfdrugvftovfonevfofvfthevffollowin
gvfcategories:vfprescription,vfnonprescription,vforvfcontrolledvfsubstance.vfMetabolitevfrefersv
ftovfthevfinactivevfformvfofvfthevfdrug.vfNoncontrolledvfsubstancevfisvfavftermvfthatvfisvfnotvfuse
d.
Pagev f 2
, TestvfBankvfforvfIntroductoryvfClinicalvfPharmacologyvf12thvfEditionvf
Ford
7. Whichvfofvfthevffollowingvfwouldvfbevfmostvfimportantvfforvfthevfnursevftovfdovftovfensurevfthe
vfsafevfusevfofvfprescriptionvfdrugsvfinvfthevfinstitutionalvfsetting? vfSelectvfallvfthatvfapply.
A) Administeringvfdrugs
B) Monitoringvfclientsvfforvfdrugvfeffects
C) Prescribingvfdrugs
D) Evaluatingvfclientsvfforvftoxicvfeffects
E) Educatingvfclients/caregiversvfaboutvfdrug
svfAns:v f A,vfB,vfD,vfE
Feedback:
Invfthevfinstitutionalvfsetting,vfthevfnurse'svfrolevftovfensurevfsafevfusevfofvfprescriptionvfdrugsvf
includesvfadministeringvfdrugs,vfmonitoringvfdrugvfeffects,vfevaluatingvfforvftoxicvfeffects,vfan
dvfeducatingvfclientsvfandvfcaregiversvfaboutvfdrugs.
8. Thevfnursevfisvfhelpingvfavfclientvfreviewvfavfprescriptionvffromvfthevfhealthvfcarevfprovider.vf
Whenvfexaminingvfthevfprescription,vfwhichvfofvfthevffollowingvfwouldvfthevfnursevfexpectvf
tovffindvfdocumented?vfSelectvfallvfthatvfapply.
A) Namevfofvfthevfdrug
B) Dosagevfofvfthevfdrug
C) Routevfofvfdrugvfadministration
D) Timesvfofvfdrugvfadministration
E) Licensedvfprescriber'svfsignatur
evfAns:v f A,vfB,vfC,vfD,vfE
Feedback:
Thevfprescriptionvfmustvfcontainvfthevfclient'svfname,vfthevfnamevfofvfthevfdrug,vfthevfdosage,vft
hevfmethodvfandvftimesvfofvfadministration,vfandvfthevfsignaturevfofvfthevflicensedvfhealthvfcar
evfprovidervfprescribingvfthevfdrug.
9. Aftervfteachingvfavfgroupvfofvfnursingvfstudentsvfaboutvfnonprescriptionvfdrugs,vfthevfnursin
gvfinstructorvfdeterminesvfthatvfthevfteachingvfwasvfsuccessfulvfwhenvfthevfstudentsvfidentifyvf
whichvfofvfthevffollowing?vfSelectvfallvfthatvfapply.
A) Theyvfrequirevfavflicensedvfhealthvfcarevfprovider'svfsignature.
B) Theyvfarevfreferredvftovfasvfover-the-countervfdrugs.
C) Theyvfcanvfbevftakenvfwithoutvfriskvftovfthevfclient.
D) Theyvfhavevfcertainvflabelingvfrequirements.
E) Theyvfshouldvfbevftakenvfonlyvfasvfdirectedvfonvfthevflab
el.vfAns:v f B,vfD,vfE
Feedback:
Nonprescriptionvfdrugsvfarevfoftenvfreferredvftovfasvfover-the-
countervf(OTC)vfdrugs.vfTheyvfdovfnotvfrequirevfavfprescriptionvf(avflicensedvfhealthvfcarevfpr
ovider'svfsignature)vfbutvfdovfnotvfcomevfwithoutvfriskvftovfthevfclient.vfThevffederalvfgovernme
ntvfhasvfimposedvflabelingvfrequirementsvfofvfOTCvfdrugsvfandvftheyvfshouldvfonlyvfbevftakenvf
asvfdirectedvfonvfthevflabelvfunlessvfundervfthevfsupervisionvfofvfavfhealthvfcarevfprovider.
Pagev f 3
